论文部分内容阅读
目的:临床观察应用文拉法辛治疗患有广泛性焦虑障碍合并慢性胃炎的患者的治疗效果。经ICD-10诊断标准广泛性焦虑障碍和慢性胃炎共识诊断标准慢性胃炎综合确诊为广泛性焦虑障碍合并慢性胃炎的患者102例,用SAS(焦虑自评量表)[1]及HAMA(汉密尔顿焦虑评定量表)[2]评估患者的焦虑障碍情况,随机将患者分成常规药物治疗组(对照组)和文拉法辛+常规药物治疗组(实验组),应用SCL-90量表(症状自评量表)[3]对患者胃镜检查前后的心理状态进行面对面问卷调查[3],在治疗4周后对患者再次进行焦虑障碍情况测评,同时对患者的慢性胃炎治疗前后症状的改善情况进行观察。
AIM: To observe the therapeutic effect of venlafaxine in the treatment of patients with generalized anxiety disorder and chronic gastritis. The diagnostic criteria of ICD-10 generalized anxiety disorders and chronic gastritis consensus diagnostic criteria of chronic gastritis comprehensive diagnosis of generalized anxiety disorder with chronic gastritis in patients with 102 cases, SAS (anxiety scale) [1] and HAMA (Hamilton Anxiety Rating Scale) [2] To evaluate the anxiety disorder in patients, patients were randomly divided into routine drug treatment group (control group) and venlafaxine + conventional drug treatment group (experimental group), SCL-90 scale Scale) [3] before and after gastroscopy in patients with psychological state of the face-to-face questionnaire [3], after 4 weeks of treatment of patients again anxiety disorders evaluation, at the same time in patients with chronic gastritis before and after treatment to improve the symptoms were observed .